The clinical utility of HPV DNA testing in cervical cancer screening strategies

Indian Journal of Medical Research

Volumn 130, Issue 3, 2009, Pages 261-265

  Bhatla, Neerja ^a   Moda, Nidhi ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cervical cancer; Cervical intraepithelial neoplasia (CIN); HPV; Screening

Indexed keywords

VIRUS DNA; WART VIRUS VACCINE;

CANCER MORTALITY; CANCER SCREENING; COLPOSCOPY; DEVELOPING COUNTRY; DNA DETERMINATION; FOLLOW UP; GYNECOLOGICAL EXAMINATION; HUMAN; NONHUMAN; POLYMERASE CHAIN REACTION; REPRODUCIBILITY; REVIEW; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VAGINA SMEAR; VIRUS DETECTION; WART VIRUS;

DNA, VIRAL; FEMALE; HUMANS; INDIA; MASS SCREENING; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; UTERINE CERVICAL NEOPLASMS;

EID: 72649086579     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide, IARC CancerBase No. 5, Version 2.0, Lyon: International Agency for Research on Cancer Press; 2004.
2. Sankaranarayanan R, Budukh A, Rajkumar R. Effective screening programs for cervical cancer in low- and middle income developing countries. Bull World Health Organ 2001; 79: 954-62.
3. Alliance for Cervical Cancer Prevention (ACCP). Planning and implementing cervical cancer prevention and control programs: A manual for managers. ACCP: Seattle, WA, USA; 2004.
4. Walboomers JM, Jacobs MV, Manos MM, Bosch X, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12-9.
5. Munoz N, Bosch Fx, de Sanjose S, Herrero R, Castellsagué X, Shah KV, et al. International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518-27.
6. Clifford GM, Smith JS, Aguado T, Franceschi S. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer 2003; 89: 101-5.
7. Bosch Fx, Lorincz A, Muñoz N, Meijer CJLM, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55: 244-65.
8. de Sanjosé S. Human papillomavirus and cancer-Epidemiology and prevention, 4th monograph of the Spanish Society of Epidemiology. Barcelona, Spain: Spanish Society of Epidemiology; 2006. p. 143-7.
9. Ramachandran S, Bhatla N, Bell L, Virmani A, Payne E, Dong L, et al. A fast affordable sensitive test for HPV in developing countries: Performance trial results from India. 24th International Papillomavirus Conference, Beijing, China; November 3-9, 2007.
10. Cuzick J, Clavel C, Petry KU, Meijer CJ, Hoyer H, Ratnam S, et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer 2006; 119: 1095-101.
11. Franco EL. Primary screening of cervical cancer with human papillomavirus tests. J Natl Cancer Inst 2003; 31: 89-96.
12. Bhatla N, Ramachandran S, Virmani A, Arora VK, Gulati A, Singla S, et al. Correlation of FastHPV and cytology: Performance trial results from India. 24th International Papillomavirus Conference, Beijing, China; November 3-9, 2007.
13. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998; 338: 423-8.
14. Wheeler CM, Greer CE, Becker TM, Hunt WC, Anderson SM, Manos MM. Short-term fluctuations in the detection of cervical human papillomavirus DNA. Obstet Gynecol 1996; 88: 261-8.
15. Kuhn L, Denny L, Pollack A, Wright TC. Human papillomavirus DNA testing for cervical cancer screening in low resource settings. J Natl Cancer Inst 2000; 92: 818-25.
16. Bhatla N, Dar L, Sankaranarayanan R, Kumar P, Patro AR, Pati S, et al. Age-specific human papillomavirus prevalence in north India. 24th International Papillomavirus Conference, Beijing, China, November 3-9, 2007; PS 8-42.
17. Sherman ME, Lorincz AT, Scott DR, Wacholder S, Castle PE, Glass AG, et al. Baseline cytology human papillomavirus testing and risk for cervical neoplasia: a 10-year cohort analysis. J Natl Cancer Inst 2003; 95: 46-52.
18. Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, Gordillo-Tobar A, Levin C, Mahe C, Wright TC; Alliance for Cervical Cancer Prevention Cost Working Group. Cost-effectiveness of cervical-cancer screening in five developing countries. N Engl J Med 2005; 353: 2158-68.
19. Wright TC Jr, Cox JT, Massad L, Twiggs LB, Wilkinson EJ; ASCCP-Sponsored Consensus Conference. Consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 2002; 287: 2120-9.
20. The atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesions triage study (ALTS) Group. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. J Natl Cancer Inst 2000; 92: 397-402.
21. Wright TC Jr, Schiffman M, Solomon D, Cox JT, Garcia F, Goldie S, et al. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet Gynecol 2004; 103: 304-9.
22. Soutter WP, de Barros Lopes A, Fletcher A, Monaghan JM, Duncan ID, Paraskevaidis E. Invasive cervical cancer after conservative therapy for cervical intraepithelial neoplasia. Lancet 1997; 349: 978-80.
23. Lorincz AT. Screening for cervical cancer: new alternatives and research. Salud Publica Mex 2003; 45 (Suppl 3): S376-S87.
24. Wright TC Jr, Denny L, Kuhn L, Pollack A, Lorincz A. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA 2000; 283: 81-6.
25. Belinson JL, Qiao YL, Pretorius RG, Zhang WH, Rong SD, Huang MN, et al. Shanxi Province cervical cancer screening study II: self-sampling for high-risk human papillomavirus compared to direct sampling for human papillomavirus and liquid based cervical cytology. Int J Gynecol Cancer 2003; 13: 819-26.
26. Bhatla N, Dar L, Pati SK, Patro AR, Kumar P, Gulati A, et al. HPV DNA testing of self-collected vaginal and physician-collected cervical samples by Hybrid Capture 2 and PCR-Reverse Line Blot Assay. 24th International Papillomavirus Conference, Beijing, China; November 3-9, 2007.
27. Garcia F, Barker B, Santos C. Cross-sectional study of patient and physician collected cervical cytology and human papillomavirus. Obstet Gynecol 2003; 102: 266-72.
28. Bernstein A, Vitner S, Webber JM. Evaluation of a new tampon device for cytology autocollection and mass screening of cervical cancer and its precursors. Am J Obstet Gynecol 1985; 151: 351-5.